Amdocs (NASDAQ:DOX) Sets New 52-Week Low – Time to Sell?

Amdocs Limited (NASDAQ:DOX)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as $65.74 and last traded at $66.6040, with a volume of 93725 shares trading hands. The stock had previously closed at $67.26.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on DOX shares. Bank of America decreased their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Barclays decreased their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Stifel Nicolaus dropped their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and an average price target of $92.33.

Amdocs Price Performance

The company has a 50 day simple moving average of $78.31 and a 200-day simple moving average of $80.86. The stock has a market cap of $7.18 billion, a price-to-earnings ratio of 12.88, a PEG ratio of 1.20 and a beta of 0.40. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.06. The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a yield of 3.4%. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is currently 40.81%.

Hedge Funds Weigh In On Amdocs

Several institutional investors have recently made changes to their positions in DOX. Pzena Investment Management LLC lifted its holdings in shares of Amdocs by 82.6% in the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after purchasing an additional 5,443,766 shares during the last quarter. LSV Asset Management increased its position in Amdocs by 0.8% in the fourth quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after buying an additional 29,829 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in Amdocs by 1.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after buying an additional 54,676 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Amdocs by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after acquiring an additional 91,900 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Amdocs by 0.3% during the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.